In addition, Cook et al. reported that glucose utility was reduced both in patients with T2DM and LV dysfunction, whereas IRS1-PI3K was unexpectedly elevated, and concluded that behaviors of insulin signaling molecules in cardiac insulin resistance are different from those of whole body insulin resistance [76]. This evidence concerns the gene INS and Insulin resistance.